3-iodobenzylguanidine has been researched along with Cardiac Output, Low in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, T; Hashimoto, A; Nakata, T; Yuda, S | 1 |
| Borm, JJ; Somsen, GA; van der Wall, EE; van Royen, EA; van Vlies, B | 1 |
| Avogaro, A; Casara, D; Crepaldi, C; Dalla Volta, S; Erle, G; Fasoli, G; Marin, M; Mingardi, R; Palisi, M; Scognamiglio, R | 1 |
3 other study(ies) available for 3-iodobenzylguanidine and Cardiac Output, Low
| Article | Year |
|---|---|
Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Output, Low; Death, Sudden, Cardiac; Electrocardiography; Female; Heart Conduction System; Heart Failure; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Stroke Volume; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2018 |
Neuronal dysfunction in heart failure assessed by cardiac 123-iodine metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Cardiac Output, Low; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Myocardium; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 1996 |
Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Agonists; Adrenergic Fibers; Adult; Body Weight; Cardiac Complexes, Premature; Cardiac Output, Low; Cardiac Volume; Cardiomyopathies; Case-Control Studies; Diabetes Mellitus, Type 1; Dobutamine; Echocardiography; Electric Stimulation; Exercise; Female; Hand Strength; Heart Conduction System; Humans; Incidence; Linear Models; Male; Myocardial Contraction; Physical Exertion; Radionuclide Imaging; Radiopharmaceuticals; Rest; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 1998 |